Home / Resources / Specialty Billing

Dermatology Medical Billing: Codes & Common Denials

By Dynamic Medical Billing Solutions · Updated October 13, 2026 · 5 min read

Dermatology is a high-volume specialty with a mix of medical, surgical and cosmetic services. That mix is what makes the billing tricky: the same visit can include an exam, a biopsy and a destruction of lesions, each with its own coding rules. This guide covers the key code families and the denials that cost dermatology practices the most.

What Makes Dermatology Billing Distinctive

• Many visits include a procedure on the same day as the E/M, which makes modifier 25 a daily issue.
• Procedure codes depend on the technique, the lesion's size, the body site and whether the lesion is benign, malignant or premalignant.
• Pathology adds a second stream of claims, billed by the lab.
• Medical and cosmetic services are intertwined, and payers do not cover cosmetic procedures.
• Biologic and injectable drugs add specialty pharmacy, buy-and-bill and prior authorization workflows.

Biopsy Codes

Skin biopsy codes depend on technique, and the first lesion and each additional lesion are coded separately.

Technique	First lesion	Each additional
Tangential (shave) biopsy	11102	11103
Punch biopsy	11104	11105
Incisional biopsy	11106	11107

Document the technique, site and number of lesions biopsied. A frequent error is coding a biopsy when the lesion was removed entirely for treatment; complete removal is usually an excision or destruction, not a biopsy.

Destruction of Lesions

• Premalignant lesions (such as actinic keratoses): 17000 for the first lesion, 17003 for each of the second through fourteenth and 17004 for 15 or more lesions.
• Benign lesions (such as warts or skin tags): 17110 for up to 14 lesions and 17111 for 15 or more. Many payers cover these only when symptomatic or with medical indication.
• Malignant lesions: destruction codes in the 17260–17286 range, selected by body area and lesion size.

Documentation needs the lesion type, number, site, size where relevant and method of destruction, such as cryosurgery, electrodesiccation or curettage. Check payer policy on whether benign lesion destruction requires a documented symptom or medical necessity.

Excisions and Repairs

Excision codes are chosen by lesion type (benign 114xx, malignant 116xx), body site and the excised diameter, which is the lesion plus the margins, measured before closure. Pathology confirmation is needed to bill malignant excision codes: when only a clinical diagnosis exists, many practices bill benign codes until the report returns, and correct the claim or hold it according to payer rules. Layered or complex repairs are coded separately from the excision, while simple repairs are included.

Mohs micrographic surgery uses a separate family (17311–17315) that depends on the site and the number of stages and tissue blocks, and requires the surgeon to act as both surgeon and pathologist for the case.

Modifier 25 With Same-Day Procedures

When a patient comes in for a skin check and has a biopsy or destruction, the E/M can be billed with modifier 25 only if it is significant and separately identifiable from the procedure. A routine, expected pre-procedure assessment is part of the procedure. The note should show a distinct problem addressed, such as a new complaint or a full-body evaluation leading to additional decisions. Payers often audit this combination in dermatology, so document carefully. Our E/M coding guide explains how to select the level correctly.

Medical vs. Cosmetic

Insurance covers services that are medically necessary. Cosmetic services such as many laser treatments, fillers and neuromodulators are not covered, and should be billed to the patient with a signed financial agreement. Removing a lesion for appearance alone is cosmetic. Removing it because it is symptomatic, is changing, has atypical features or is suspicious of malignancy is medical, and the note should say so. Poor documentation of the reason is the most common cause of denials in this area, and the opposite problem (billing insurance for a cosmetic service) is a compliance risk.

Drugs, Biologics and Prior Authorization

Biologics and other injectables for conditions such as psoriasis, atopic dermatitis and hidradenitis suppurativa usually require prior authorization with documented prior treatments, diagnosis and severity. Practices that buy and bill drugs must also handle J-codes, units, NDC numbers and wastage reporting where the payer requires it. Others route the patient to a specialty pharmacy; in that case, document the benefits investigation and prior authorization steps so the claim for the visit is clean.

Common Dermatology Denials and Fixes

• E/M denied with a procedure — modifier 25 missing, or documentation does not show a separate service.
• Benign lesion destruction denied as cosmetic — document symptoms (itching, bleeding, irritation, inflammation) or suspicious features.
• Biopsy bundled with excision or destruction of the same lesion — only bill separately when different lesions or distinct sites were treated, and use X modifiers appropriately.
• Frequency limits on actinic keratosis treatment or skin exams — check payer policy and prior dates.
• Missing pathology link — make sure the pathology report is received and filed so malignant codes are supported.
• Prior authorization missing for drugs (CO-197).

These are the kinds of patterns that denial management and a targeted billing audit are built to catch. See our physicians' billing services for the full workflow.

This article is educational and not a substitute for current CPT descriptors or payer policy.

Revenue Cycle Tips for Dermatology Practices

Because dermatology is a high-volume specialty, small leaks add up. Start with charge capture: make sure every biopsy, destruction and additional lesion is captured on the superbill, and reconcile against the pathology log each week so every specimen sent to the lab has a matching charge. Use templates for procedure notes that prompt for site, size, technique and number of lesions, since those details drive code selection and payment.

Keep a payer-specific cheat sheet for frequency limits on treatments such as actinic keratosis destruction and for policy on benign lesion removal. Verify eligibility before every visit, because patients who come in for a skin check often have changed plans. Finally, separate your cosmetic and medical schedules, pricing and financial agreements so that cosmetic services are never submitted to insurance by mistake. A short monthly review of denials by code and payer will show where front-desk or coding fixes are needed.

Frequently Asked Questions

When can a dermatology E/M be billed with a procedure?

When a significant, separately identifiable evaluation is documented in addition to the procedure, with modifier 25 appended. A routine assessment before a biopsy or destruction is considered part of the procedure.

Why are wart or skin tag removals denied?

Many payers treat removal of benign lesions as cosmetic unless there is a documented medical reason, such as pain, bleeding, irritation, infection or suspicion of malignancy. Document the symptom or feature in the note.

How do biopsy codes differ from excision codes?

A biopsy takes a sample of a lesion for diagnosis, using tangential, punch or incisional techniques. An excision removes the lesion with margins and is coded by lesion type, site and excised diameter.

Do I need prior authorization for biologics?

Usually, yes. Payers typically require documentation of the diagnosis, severity and previous treatments. Process the benefits check and authorization before the first dose, and keep the approval details in the chart.

How should cosmetic services be billed?

Cosmetic services are not covered by insurance and should be billed to the patient, with a signed financial agreement and a clear price in advance.